25 Sept. 2003 Frankfurt, Germany1 U.S. FDA Approach to Auditing Including QSIT Christine Nelson...

Post on 30-Mar-2015

217 views 1 download

Tags:

transcript

25 Sept. 2003 Frankfurt, Germany 1

U.S. FDA Approach to Auditing Including QSIT

Christine Nelson

Center for Devices & Radiological Health

Food & Drug Administration

25 Sept. 2003 Frankfurt, Germany 2

FDA-Speak Terms

Inspection = Audit

Investigator = Auditor

25 Sept. 2003 Frankfurt, Germany 3

Why does FDA inspect device manufacturers?

To evaluate compliance with the following FDA device regulations: Quality Systems Medical Device Reporting Medical Device Tracking Reports of Corrections and

Removals Registration and Listing

25 Sept. 2003 Frankfurt, Germany 4

Who conducts inspections for FDA?

1. FDA investigators in 20 FDA District Offices around the U.S.

2. FDA-trained Auditors from Conformity Assessment Bodies in the European Union (EU)

3. In the future, FDA-trained auditors from independent third parties accredited by FDA

25 Sept. 2003 Frankfurt, Germany 5

How does FDA decide who to inspect?

Registration database identifies who manufactures devices for distribution in the U.S.

Listing database identifies what devices they distribute

FDA prioritizes inspections by risk and gives higher risk devices/situations a higher priority

25 Sept. 2003 Frankfurt, Germany 6

What is high priority for inspection?

Device manufacturers that: Make class III devices

Make implantable devices and life supporting and life sustaining devices

Recently introduced a new device to the market

Have had significant violations in the past

25 Sept. 2003 Frankfurt, Germany 7

Does FDA notify the manufacturer of an upcoming inspection?

FDA calls domestic manufacturers about 5 days before the inspection

FDA contacts foreign manufacturers 2 - 3 months in advance to schedule inspection

Manufacturer is requested to send Quality System Manual or equivalent for pre-inspection review

25 Sept. 2003 Frankfurt, Germany 8

What happens when the FDA investigator arrives at the site?The FDA investigator will:

Ask to see the top management

Present credentials (identifies person as an FDA investigator)

Issue notice of inspection explaining FDA’s legal authority to inspect (only in the U.S.)

25 Sept. 2003 Frankfurt, Germany 9

What happens during the inspection? Investigator may tour the facility to get

an idea of layout, workflow, and areas

that may need closer inspection

This helps the investigator

decide how to organize

the inspection

25 Sept. 2003 Frankfurt, Germany 10

What happens next?

The investigator will: Ask about size and structure of

company, who is in charge, what products are manufactured there

Review registration and listingEvaluate compliance with FDA

regulations using the Quality System Inspection Technique (QSIT)

25 Sept. 2003 Frankfurt, Germany 11

What is QSIT?

GGUIDEUIDE TOTO I INSPECTIONSNSPECTIONS OFOF QQUALITYUALITY S SYSTEMSYSTEMS

FOOD AND DRUG ADMINISTRATION

August 1999August 1999

www.fda.gov/ora/inspect_ref/igs/qsit/qsitguide.htm

25 Sept. 2003 Frankfurt, Germany 12

What is QSIT?

Identifies 4 major subsystems to evaluate and states the purpose and importance of each subsystem

Provides flowcharts and inspectional objectives to cover during inspection

Offers advice Provides tables for statistical sampling

of records for review

25 Sept. 2003 Frankfurt, Germany 13

What are the four main subsystems?

Design Controls

MaterialControls Records,

Documents, &Change Controls

Equipment & Facility Controls

Production & Process Controls

Corrective &Preventive

Actions

Management

25 Sept. 2003 Frankfurt, Germany 14

What does FDA look for in the Management Subsystem?Quality Policy established?

Management representative appointed?

Management reviews conducted?

25 Sept. 2003 Frankfurt, Germany 15

What does FDA look for in the Management Subsystem?Quality audit procedures

established and quality audits conducted?

Quality plan established?

Quality system procedures established?

25 Sept. 2003 Frankfurt, Germany 16

What does FDA look for in the Design Control Subsystem? Design procedures and plan established?

Design inputs or requirements for device identified?

Design outputs or specifications for device identified?

Design verification conducted?

Design validation conducted?

25 Sept. 2003 Frankfurt, Germany 17

What does FDA look for in the Design Control Subsystem?Software validation completed?

Risk analysis carried out?

Design reviews conducted?

Design transfer to manufacturing completed successfully?

25 Sept. 2003 Frankfurt, Germany 18

What does FDA look for in the Corrective and Preventive Action Subsystem?

CAPA procedures established?

Sources of data analyzed to identify nonconforming product and quality problems?

Statistical analysis across data sources?

Investigations conducted to identify root cause of failures?

25 Sept. 2003 Frankfurt, Germany 19

What does FDA look for in the Corrective and Preventive Action Subsystem?

Nonconforming product controlled?

Appropriate corrective actions and preventive actions carried out?

Those responsible are told about CAPA activities?

Management review of CAPA activities?

25 Sept. 2003 Frankfurt, Germany 20

What does FDA look for in the Production and Process Control Subsystem?

Processes are controlled and monitored?

Any rejects or nonconforming product?

Equipment adjusted, calibrated and maintained?

25 Sept. 2003 Frankfurt, Germany 21

What does FDA look for in the Production and Process Control Subsystem?

Manufacturing processes validated or fully verified?

Software validated?

Production employees trained and qualified?

25 Sept. 2003 Frankfurt, Germany 22

What about the other subsystems?

The other three subsystems are covered through links with the four main subsystems:

Records, documents and change control

Facility and equipment control

Material control

25 Sept. 2003 Frankfurt, Germany 23

What happens at the end of the inspection? The investigator will:

Meet with management to discuss the inspection

Present the FDA 483 list of observations of any significant deficiencies

Discuss the deficiencies

25 Sept. 2003 Frankfurt, Germany 24

What should the manufacturer do after the inspection? Send a letter to FDA identifying how they

have corrected deficiencies or will correct them

Provide documentation of any corrections that have been completed

Provide a timetable or estimated completion date for future corrections

25 Sept. 2003 Frankfurt, Germany 25

Where should I send the letter?

Office of Compliance

Center for Devices and Radiological Health (CDRH)

Food and Drug Administration

2094 Gaither Road, HFZ-300

Rockville, Maryland 20850

U.S.A.

25 Sept. 2003 Frankfurt, Germany 26

Center for Devices & Radiological HealthOffice of the

Center Director

Office of Device Evaluation

Office of In Vitro DiagnosticDevice Evaluation & Safety

Office of Compliance

Office of Surveillance& Biometrics

Office of Science& Technology

Office of Systems& Management

Office of Health &Industry Programs

Division of Small Manufacturers,International & Consumer Assistance

25 Sept. 2003 Frankfurt, Germany 27

Office of Compliance

Division of Enforcement A

Dental, ENT & Ophthalmic Devices

OB/GYN, Gastro & Urology Devices

General Hospital Devices

General Surgery Devices

Division of Enforcement B

Cardiovascular & Neurological Devices

Diagnostic X-ray Devices

Electronic Products & Devices

Orthopedic, Physical Medicine & Anesthesiology Devices

25 Sept. 2003 Frankfurt, Germany 28

What happens next?

Investigator writes an “Establishment Inspection Report” or EIR

EIR is sent to the Office of Compliance, Center for Devices and Radiological Health (CDRH)

Inspection is classified based on inspectional findings

Office of Compliance reviewer writes Warning Letter for inspection classified “OAI”

25 Sept. 2003 Frankfurt, Germany 29

How does FDA classify inspection reports? NAI – No action indicated

VAI – Voluntary action indicated – some deficiencies identified but not serious

OAI – Official action indicated – serious deficiencies identified, and FDA must take action to assure correction

25 Sept. 2003 Frankfurt, Germany 30

What actions can FDA take to address OAI inspections?

For device manufacturers outside the U.S.:

Warning Letter

Warning Letter + Automatic Detention

25 Sept. 2003 Frankfurt, Germany 31

Warning Letter

FDA sends “Warning Letter” describing manufacturer’s violations of FDA regulations and requesting a reply within 15 days

25 Sept. 2003 Frankfurt, Germany 32

Warning Letter + Automatic Detention

FDA sends “Warning Letter” describing manufacturer’s violations of FDA regulations and requesting a reply within 15 days

Manufacturer’s products are put on automatic detention to prevent them from entering the U.S.

25 Sept. 2003 Frankfurt, Germany 33

What will the Warning Letter say about Automatic Detention? Given the serious nature of these violations of

the Act, all products manufactured at this facility may be detained without physical examination upon entry into the United States. In order to prevent your devices from being detained without physical exam, your firm will need to respond to this Warning Letter (as set forth below) and correct the violations noted in this letter. In addition, the agency usually needs to conduct a follow-up inspection to verify that the appropriate corrections have been implemented.

25 Sept. 2003 Frankfurt, Germany 34

How do I get my devices off automatic detention?

Submit documentation to FDA showing that deficiencies have been corrected

FDA will inspect you to confirm that corrections are adequate before lifting automatic detention

25 Sept. 2003 Frankfurt, Germany 35

Where can I get more information about FDA inspections and regulations?

QSIT:

http://www.fda.gov/ora/inspect_ref/igs/qsit/QSITGUIDE.PDF

http://www.fda.gov/ora/inspect_ref/igs/qsit/qsitguide.htm

Inspections of Medical Device Manufacturers Compliance Program 7382.845: http://www.fda.gov/ora/cpgm/default.htm#devices More . . .

25 Sept. 2003 Frankfurt, Germany 36

Where can I get more information about FDA inspections and regulations?

Quality system regulation: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=820

General quality system info: http://www.fda.gov/cdrh/devadvice/32.html

Investigations Operations Manual: http://www.fda.gov/ora/inspect_ref/iom/default.htm

More . . .

25 Sept. 2003 Frankfurt, Germany 37

Where can I get more information about FDA inspections and regulations?

Other medical device regulations: http://www.fda.gov/cdrh/devadvice/

Division of Small Manufacturers, International and Consumer Assistance - E-mail: dsma@cdrh.fda.gov

Christine Nelson – E-mail: mcn@cdrh.fda.gov

25 Sept. 2003 Frankfurt, Germany 38

Summary

Quality System Inspection Technique (QSIT)

How FDA conducts inspections

What should a manufacturer do after an inspection

Warning Letter or Warning Letter + Automatic Detention

Where to go for more information